BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16703484)

  • 1. [A new concept for the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD)].
    Ewig S; Schaberg T
    Pneumologie; 2006 May; 60(5):295-304. PubMed ID: 16703484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: analysis of comparative trials].
    Garré M; Garo B; Ansart S; Le Berre R
    Med Mal Infect; 2006; 36(11-12):690-6. PubMed ID: 16824719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical inquiries: When are antibiotics indicated for acute COPD exacerbations?
    Balser E; Neher JO; Safranek S; Taraday J
    J Fam Pract; 2006 Dec; 55(12):1079-80. PubMed ID: 17137546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease].
    Cavassini M; Calandra T; Bridevaux PO
    Rev Med Suisse; 2007 Apr; 3(106):939-42. PubMed ID: 17575969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations.
    Simoens S; Decramer M; De Coster S; Celis G; Laekeman G
    Int J Clin Pract; 2007 Feb; 61(2):200-6. PubMed ID: 17263707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counting, analysing and reporting exacerbations of COPD in randomised controlled trials.
    Aaron SD; Fergusson D; Marks GB; Suissa S; Vandemheen KL; Doucette S; Maltais F; Bourbeau JF; Goldstein RS; Balter M; O'Donnell D; Fitzgerald M;
    Thorax; 2008 Feb; 63(2):122-8. PubMed ID: 17702790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
    Simoens S; Decramer M; Laekeman G
    Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].
    Burgel PR
    Med Mal Infect; 2006; 36(11-12):706-17. PubMed ID: 16839731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decision guidance for antibiotic treatment of acute exacerbation of COPD].
    Kolditz M; Höffken G
    MMW Fortschr Med; 2007 Mar; 149(11):38-40; quiz 41. PubMed ID: 20104700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Sethi S
    Semin Respir Crit Care Med; 2005 Apr; 26(2):192-203. PubMed ID: 16088436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
    Chelidze K; Jgarkava M
    Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.
    El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM
    Thorax; 2008 May; 63(5):415-22. PubMed ID: 18234905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al.
    Sethi S
    BMC Med; 2008 Oct; 6():29. PubMed ID: 18847482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Sethi S
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S177-85. PubMed ID: 15942884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new measure of acute physiological derangement for patients with exacerbations of obstructive airways disease: the COPD and Asthma Physiology Score.
    Wildman MJ; Harrison DA; Welch CA; Sanderson C
    Respir Med; 2007 Sep; 101(9):1994-2002. PubMed ID: 17616454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erdosteine for COPD exacerbations.
    Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
    Niewoehner DE
    Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.